Kosedo T, Kashiwagi N, Nagano M, Makita H, Adachi M, Sata M, Tanikawa K
Japan Immunoresearch Laboratories Co. Ltd., Takasaki.
Rinsho Byori. 1991 Jun;39(6):627-32.
We developed a new assay method for the evaluation of Le(Y) antigen expression on human peripheral T-lymphocytes using the monoclonal antibodies BM-1, CD4 and CD8 by two-color flow cytometry. Le(Y) antigen expressed on human peripheral T-lymphocytes was stained with fluorescein isothiocyanate (FITC)-labelled BM-1 (anti Le(Y) monoclonal antibody). Le(Y) positive cells were simultaneously stained with phycoerythrin (PE)-labelled CD4 or CD8, then analyzed by flow-cytometer. Coefficients of variations in this double staining assays were 4.2% for BM-1 in CD4 and 5.3% for BM-1 in CD8, respectively. In 124 healthy volunteers 0.2-13.1% of CD4 and 2.5-12.5% of CD8 positive cells were BM-1 positive. Lymphocytes from 200 patients with acute or chronic viral hepatitis showed marked increase in BM-1 expression of CD8 positive cells during the acute phase and exacerbation of the disease. Moreover, BM-1 expression of CD4 cells was positively related with the course of the chronic hepatitis and the prognosis of each patients. Therefore, this new assay using BM-1 and CD4, CD8 monoclonal antibodies would reflect progression of viral hepatitis and its related immunological condition.
我们开发了一种新的检测方法,通过双色流式细胞术,使用单克隆抗体BM-1、CD4和CD8来评估人外周血T淋巴细胞上Le(Y)抗原的表达。用人外周血T淋巴细胞上表达的Le(Y)抗原与异硫氰酸荧光素(FITC)标记的BM-1(抗Le(Y)单克隆抗体)进行染色。Le(Y)阳性细胞同时用藻红蛋白(PE)标记的CD4或CD8进行染色,然后通过流式细胞仪进行分析。在这种双重染色检测中,BM-1在CD4中的变异系数分别为4.2%,在CD8中为5.3%。在124名健康志愿者中,0.2 - 13.1%的CD4阳性细胞和2.5 - 12.5%的CD8阳性细胞为BM-1阳性。来自200例急性或慢性病毒性肝炎患者的淋巴细胞在急性期和疾病加重期显示CD8阳性细胞的BM-1表达明显增加。此外,CD4细胞的BM-1表达与慢性肝炎的病程及各患者的预后呈正相关。因此,这种使用BM-1和CD4、CD8单克隆抗体的新检测方法将反映病毒性肝炎的进展及其相关的免疫状况。